Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directionsNeuro-oncology 2022 Oct 12;[EPub Ahead of Print], JJ Miller, LN Gonzalez Castro, S McBrayer, M Weller, T Cloughesy, J Portnow, O Andronesi, JS Barnholtz-Sloan, BG Baumert, MS Berger, WL Bi, R Bindra, DP Cahill, SM Chang, JF Costello, C Horbinski, RY Huang, RB Jenkins, KL Ligon, IK Mellinghoff, LB Nabors, M Platten, DA Reardon, DD Shi, D Schiff, W Wick, H Yan, A von Deimling, M van den Bent, WG Kaelin, PY Wen
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.